Inspiremd announces inducement grants under nasdaq listing rule 5635(c)(4)

Miami, feb. 04, 2025 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ prime carotid stent system for the prevention of stroke, today announced that the compensation committee of inspiremd's board of directors approved inducement grants to one new non-executive employee in the amount of 18,000 shares of restricted stock outside of inspiremd's 2021 equity compensation plan, with a grant date as of january 7, 2025, as an inducement material to the employee entering into employment with inspiremd, in accordance with nasdaq listing rule 5635(c)(4).
NSPR Ratings Summary
NSPR Quant Ranking